1. Post-approval evaluation of effectiveness of risk minimisation: methods, challenges and interpretation;Banerjee;Drug Saf,2014
2. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use Off J Eur Union 2010 L 348 74 99
3. Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products Off J Eur Union 2010 L 348 1 16
4. Methodological approaches to evaluate the impact of FDA drug safety communications;Kesselheim;Drug Saf,2015